LumiraDx Alpha and Beta Analysis
| LMDXDelisted Stock | USD 0.42 0.02 4.55% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as LumiraDx. It also helps investors analyze the systematic and unsystematic risks associated with investing in LumiraDx over a specified time horizon. Remember, high LumiraDx's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to LumiraDx's market risk premium analysis include:
Beta (0.20) | Alpha (0.81) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
LumiraDx |
LumiraDx Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. LumiraDx market risk premium is the additional return an investor will receive from holding LumiraDx long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in LumiraDx. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate LumiraDx's performance over market.| α | -0.81 | β | -0.2 |
LumiraDx Fundamentals Vs Peers
Comparing LumiraDx's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LumiraDx's direct or indirect competition across all of the common fundamentals between LumiraDx and the related equities. This way, we can detect undervalued stocks with similar characteristics as LumiraDx or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LumiraDx's fundamental indicators could also be used in its relative valuation, which is a method of valuing LumiraDx by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare LumiraDx to competition |
| Fundamentals | LumiraDx | Peer Average |
| Return On Equity | -15.64 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Profit Margin | (2.67) % | (1.27) % |
| Operating Margin | (2.31) % | (5.51) % |
| Current Valuation | 440.16 M | 16.62 B |
| Shares Outstanding | 161.02 M | 571.82 M |
| Shares Owned By Insiders | 55.41 % | 10.09 % |
LumiraDx Opportunities
LumiraDx Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | LumiraDx Submits Dual FDA Medical Device Application for Covid-19 Test | 06/30/2023 |
About LumiraDx Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including LumiraDx or other delisted stocks. Alpha measures the amount that position in LumiraDx has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
LumiraDx Upcoming Company Events
As portrayed in its financial statements, the presentation of LumiraDx's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LumiraDx's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of LumiraDx's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of LumiraDx. Please utilize our Beneish M Score to check the likelihood of LumiraDx's management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with LumiraDx
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |